SAREPTA THERAPEUTICS, INC. Long-term Purchase Commitment, Amount
SAREPTA THERAPEUTICS, INC. (SRPT) reported Long-term Purchase Commitment, Amount of $54.70 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-11-06.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2024-11-06
- SAREPTA THERAPEUTICS, INC. long-term purchase commitment, amount for the quarter ending 2023-03-31 was $54.70M.
| Period end | Long-term Purchase Commitment, Amount 3 month |
|---|---|
| 2023-03-31 | $54.70M 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |